Literature DB >> 26424099

[Experimental and therapeutic neuromodulation of emotion and social cognition with non-invasive brain stimulation].

C Mielacher1, D Scheele1, R Hurlemann2.   

Abstract

Transcranial magnetic stimulation (TMS) is not only a highly elegant method for basic neuroscientific research that employs transient lesions to explore the relationship between brain structure and function but in a clinical context it is also a very promising approach to augmentation therapy in middle to severe grade depressive episodes. This overview illustrates the methodological basis of TMS and illuminates its neuromodulatory potential with reference to findings from recent studies on emotion regulation and social cognition. Against this empirical background, it becomes clear that preclinical studies on healthy participants are extremely important to develop innovative stimulation protocols and define functionally relevant target regions to be tested in clinical studies for therapeutic efficacy. Finally, the perspectives and limitations of functionally guided, individualized TMS neuronavigation will be explored based on task-independent connectivity and task-dependent activity measurements.

Entities:  

Keywords:  Dorsolateral prefrontal cortex; Functional connectivity; Stimulation targets; Transcranial magnetic stimulation; Virtual lesions

Mesh:

Year:  2015        PMID: 26424099     DOI: 10.1007/s00115-015-4324-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  37 in total

1.  Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation.

Authors:  Uwe Herwig; Peyman Satrapi; Carlos Schönfeldt-Lecuona
Journal:  Brain Topogr       Date:  2003       Impact factor: 3.020

2.  Frequency specific changes in regional cerebral blood flow and motor system connectivity following rTMS to the primary motor cortex.

Authors:  Elisabeth Rounis; Lucy Lee; Hartwig R Siebner; James B Rowe; Karl J Friston; John C Rothwell; Richard S J Frackowiak
Journal:  Neuroimage       Date:  2005-05-15       Impact factor: 6.556

3.  Long-lasting enhancements of memory and hippocampal-cortical functional connectivity following multiple-day targeted noninvasive stimulation.

Authors:  Jane X Wang; Joel L Voss
Journal:  Hippocampus       Date:  2015-02-11       Impact factor: 3.899

4.  Diminishing reciprocal fairness by disrupting the right prefrontal cortex.

Authors:  Daria Knoch; Alvaro Pascual-Leone; Kaspar Meyer; Valerie Treyer; Ernst Fehr
Journal:  Science       Date:  2006-10-05       Impact factor: 47.728

5.  Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity.

Authors:  Michael D Fox; Hesheng Liu; Alvaro Pascual-Leone
Journal:  Neuroimage       Date:  2012-11-07       Impact factor: 6.556

6.  Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate.

Authors:  Michael D Fox; Randy L Buckner; Matthew P White; Michael D Greicius; Alvaro Pascual-Leone
Journal:  Biol Psychiatry       Date:  2012-06-01       Impact factor: 13.382

Review 7.  Physiology of repetitive transcranial magnetic stimulation of the human brain.

Authors:  Janna Marie Hoogendam; Geert M J Ramakers; Vincenzo Di Lazzaro
Journal:  Brain Stimul       Date:  2009-11-24       Impact factor: 8.955

8.  Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex.

Authors:  Antonio P Strafella; Tomás Paus; Maria Fraraccio; Alain Dagher
Journal:  Brain       Date:  2003-08-22       Impact factor: 13.501

9.  Time-course of "off-line" prefrontal rTMS effects--a PET study.

Authors:  C Eisenegger; V Treyer; E Fehr; D Knoch
Journal:  Neuroimage       Date:  2008-04-20       Impact factor: 6.556

10.  Default mode network mechanisms of transcranial magnetic stimulation in depression.

Authors:  Conor Liston; Ashley C Chen; Benjamin D Zebley; Andrew T Drysdale; Rebecca Gordon; Bruce Leuchter; Henning U Voss; B J Casey; Amit Etkin; Marc J Dubin
Journal:  Biol Psychiatry       Date:  2014-02-05       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.